Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Idera Pharmaceuticals (IDRA)

2   -0.12 (-5.66%) 06-03 16:00
Open: 2.13 Pre. Close: 2.12
High: 2.13 Low: 1.98
Volume: 551,966 Market Cap: 67M
Idera Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in the discovery, development and commercialization of novel therapeutics for oncology and rare diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.132 - 2.145 2.145 - 2.156
Low: 1.953 - 1.966 1.966 - 1.977
Close: 1.982 - 2.002 2.002 - 2.02

Technical analysis

as of: 2020-06-03 4:30:33 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 2.60     One year: 2.98
Support: Support1: 1.71    Support2: 1.42
Resistance: Resistance1: 2.23    Resistance2: 2.55
Pivot: 1.83
Moving Average: MA(5): 1.88     MA(20): 1.85
MA(100): 1.66     MA(250): 2.11
MACD: MACD(12,26): 0.04     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 37.88     %D(3): 27.14
RSI: RSI(14): 59.29
52-week: High: 3.58  Low: 0.81  Change(%): -24.0
Average Vol(K): 3-Month: 25630  10-Days: 53250

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
IDRA has closed below upper band by 6.7%. Bollinger Bands are 14.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 03 Jun 2020
Idera Pharmaceuticals Inc. [IDRA] Stock trading around $2.12 per share: What’s Next? - The DBT News

Tue, 02 Jun 2020
Idera Pharmaceuticals, Inc. (IDRA): What is good about stock? - Marketing Sentinel

Tue, 02 Jun 2020
Idera Pharmaceuticals Announces Preliminary Data From and Planned Continuation of the ILLUMINATE-206 Trial for the Treatment of Micro-Satellite Stable Colorectal Cancer - GlobeNewswire

Wed, 20 May 2020
Idera Pharmaceuticals Inc. (IDRA) Soars 2.86% on May 20 -

Tue, 02 Jun 2020
Can Idera Pharmaceuticals Inc. (NASDAQ:IDRA) Offer Investors Safety? - State Reviewer

Tue, 02 Jun 2020
$IDRA Idera Pharmaceuticals Files For Resale Of Up To 6.1 Million Shares By Selling Stockholder - CML News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 34
Shares Float (M) 25
% Held by Insiders 18.24
% Held by Institutions 27.53
Shares Short (K) 422
Shares Short P. Month (K) 513

Stock Financials

EPS -2.270
EPS Est This Year -0.480
EPS Est Next Year -0.500
Book Value (p.s.)
Profit Margin
Operating Margin -3300.62
Return on Assets (ttm) -60.3
Return on Equity (ttm) -132.3
Qtrly Rev. Growth
Gross Profit (p.s.) -0.715
Sales Per Share 0.043
EBITDA (p.s.) -1.415
Qtrly Earnings Growth
Operating Cash Flow (M) -42
Levered Free Cash Flow (M) 1

Stock Valuations

PE Ratio -0.88
PEG Ratio
Price to Book value
Price to Sales 46.48
Price to Cash Flow -1.61

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.